[Congressional Record Volume 163, Number 7 (Wednesday, January 11, 2017)]
[Senate]
[Page S287]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 144. Ms. KLOBUCHAR (for herself and Ms. Warren) submitted an 
amendment intended to be proposed by her to the concurrent resolution 
S. Con. Res. 3, setting forth the congressional budget for the United 
States Government for fiscal year 2017 and setting forth the 
appropriate budgetary levels for fiscal years 2018 through 2026; which 
was ordered to lie on the table; as follows:

       At the end of title IV, add the following:

     SEC. 4__. POINT OF ORDER AGAINST LEGISLATION THAT WOULD 
                   RESTRICT TRANSPARENCY IN THE RELATIONSHIP 
                   BETWEEN PHYSICIANS AND MANUFACTURERS OF DRUGS, 
                   DEVICES, BIOLOGICAL PRODUCTS, OR MEDICAL 
                   SUPPLIES, INCLUDING THROUGH REPEAL OF THE 
                   PHYSICIAN PAYMENTS SUNSHINE ACT PROVIDED UNDER 
                   THE PATIENT PROTECTION AND AFFORDABLE CARE ACT.

       (a) Point of Order.--It shall not be in order in the Senate 
     to consider any bill, joint resolution, motion, amendment, 
     amendment between the Houses, or conference report that would 
     restrict transparency in the relationship between physicians 
     and manufacturers of drugs, devices, biological products, or 
     medical supplies, including through repeal of the Physician 
     Payments Sunshine Act provided under section 6002 of the 
     Patient Protection and Affordable Care Act.
       (b) Waiver and Appeal.--Subsection (a) may be waived or 
     suspended in the Senate only by an affirmative vote of three-
     fifths of the Members, duly chosen and sworn. An affirmative 
     vote of three-fifths of the Members of the Senate, duly 
     chosen and sworn, shall be required to sustain an appeal of 
     the ruling of the Chair on a point of order raised under 
     subsection (a).
                                 ______